Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells

Stem Cells

Volumn 31, Issue 4, 2013, Pages 765-775

  Zafir, Ayesha ^a   Readnower, Ryan ^a   Long, Bethany W ^a   McCracken, James ^a   Aird, Allison ^a   Alvarez, Alejandro ^a   Cummins, Timothy D ^a   Li, Qianhong ^a   Hill, Bradford G ^a   Bhatnagar, Aruni ^a   Prabhu, Sumanth D ^a,b   Bolli, Roberto ^a   Jones, Steven P ^a  

^a University of Louisville School of Medicine   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adult stem cells; Cardiac; Cell biology; Hypoxia; Tissue specific stem cells

Indexed keywords

CASPASE 3; CASPASE 7; CRE RECOMBINASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE TRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; TRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIAC STEM CELL; CELL HYPOXIA; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GAIN OF FUNCTION MUTATION; GENE DELETION; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PROTEIN MODIFICATION; PROTEIN N ACETYLGLUCOSAMINATION; REOXYGENATION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; MALE; MICE; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; N-ACETYLGLUCOSAMINYLTRANSFERASES; SIGNAL TRANSDUCTION; STEM CELLS;

MAMMALIA; MURINAE;

EID: 84875773673     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1325     Document Type: Article

References (57)

1. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14.
2. Kajstura J, Leri A, Finato N et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95: 8801-8805.
3. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344:1750-1757.
4. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114: 763-776.
5. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005;85:1373-1416.
6. Rota M, Padin-Iruegas ME, Misao Y et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008;103:107-116.
7. Fischer KM, Cottage CT, Wu W et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009;120:2077-2087.
8. Bolli R, Chugh AR, D'Amario D et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011;378:1847-1857.
9. Dib N, Michler RE, Pagani FD et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Four-year follow-up. Circulation 2005;112:1748-1755.
10. Menasche P, Alfieri O, Janssens S et al. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200.
11. Meyer GP, Wollert KC, Lotz J et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113: 1287-1294.
12. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrowderived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006;367:113-121.
13. Schachinger V, Erbs S, Elsasser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006;27:2775-2783.
14. Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
15. Hare JM, Traverse JH, Henry TD et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-2286.
16. Makkar RR, Smith RR, Cheng K et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 2012; 379:895-904.
17. Malliaras K, Kreke M, Marban E. The stuttering progress of cell therapy for heart disease. Clin Pharmacol Ther 2011;90:532-541.
18. Mohsin S, Siddiqi S, Collins B et al. Empowering adult stem cells for myocardial regeneration. Circ Res 2011;109:1415-1428.
19. Gude N, Muraski J, Rubio M et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 2006;99:381-388.
20. D'Amario D, Cabral-Da-Silva MC, Zheng H et al. Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res 2011;108:1467-1481.
21. Jones SP, Zachara NE, Ngoh GA et al. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation 2008;117: 1172-1182.
22. Ngoh GA, Watson LJ, Facundo HT et al. Non-canonical glycosyl-transferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol 2008;45: 313-325.
23. Ngoh GA, Facundo HT, Hamid T et al. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ Res 2009;104:41-49.
24. Watson LJ, Facundo HT, Ngoh GA et al. O-linked beta-N-acetylglu-cosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci USA 2010;107:17797-17802.
25. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. Am J Physiol Cell Physiol 2007;292:C178-C187.
26. Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol 2008;294:C1509-C1520.
27. Zou L, Yang S, Champattanachai V et al. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol 2009;296:H515-H523.
28. Ngoh GA, Hamid T, Prabhu SD et al. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am J Physiol Heart Circ Physiol 2009;297:H1711-H1719.
29. Ngoh GA, Facundo HT, Zafir A et al. O-GlcNAc signaling in the cardiovascular system. Circ Res 2010;107:171-185.
30. Messina E, De Angelis L, Frati G et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95:911-921.
31. Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005;102:8966-8971.
32. Anversa P, Kajstura J, Leri A et al. Life and death of cardiac stem cells: A paradigm shift in cardiac biology. Circulation 2006;113: 1451-1463.
33. Di Nardo P, Forte G, Ahluwalia A et al. Cardiac progenitor cells: Potency and control. J Cell Physiol 2010;224:590-600.
34. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100:12313-12318.
35. Matsuura K, Nagai T, Nishigaki N et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004;279: 11384-11391.
36. Pfister O, Mouquet F, Jain M et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005;97:52-61.
37. Li Q, Guo Y, Ou Q et al. Intracoronary administration of cardiac stem cells in mice: A new, improved technique for cell therapy in murine models. Basic Res Cardiol 2011;106:849-864.
38. Fransioli J, Bailey B, Gude NA et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 2008;26:1315-1324.
39. Gross BJ, Kraybill BC, Walker S. Discovery of O-GlcNAc transferase inhibitors. J Am Chem Soc 2005;127:14588-14589.
40. Yuzwa SA, Macauley MS, Heinonen JE et al. A potent mechanisminspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 2008;4:483-490.
41. Ngoh GA, Watson LJ, Facundo HT et al. Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes. Amino Acids 2011;40:895-911.
42. Brar BK, Stephanou A, Wagstaff MJ et al. Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress. J Mol Cell Cardiol 1999;31: 135-146.
43. Hill BG, Dranka BP, Zou L et al. Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J 2009;424:99-107.
44. Sansbury BE, Jones SP, Riggs DW et al. Bioenergetic function in cardiovascular cells: The importance of the reserve capacity and its biological regulation. Chem Biol Interact 2011;191:288-295.
45. Sansbury BE, Riggs DW, Brainard RE et al. Responses of hypertrophied myocytes to reactive species: Implications for glycolysis and electrophile metabolism. Biochem J 2011;435:519-528.
46. Readnower RD, Brainard RE, Hill BG et al. Standardized bioenergetic profiling of adult mouse cardiomyocytes. Physiol Genomics 2012;44: 1208-1213.
47. Kang JG, Park SY, Ji S et al. O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation. J Biol Chem 2009;284:34777-34784.
48. Zachara NE, O'Donnell N, Cheung WD et al. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 2004;279: 30133-30142.
49. Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 2004;1673: 13-28.
50. Kazemi Z, Chang H, Haserodt S et al. O-linked beta-N-acetylglucos-amine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner. J Biol Chem 2010;285: 39096-39107.
51. Zachara NE. The roles of O-linked beta-N-acetylglucosamine in cardiovascular physiology and disease. Am J Physiol Heart Circ Physiol 2012;302:H1905-H1918.
52. Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 2007;42:177-185.
53. Not LG, Brocks CA, Vamhidy L et al. Increased O-linked beta-N-acetylglucos-amine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats. Crit Care Med 2010;38:562-571.
54. Fulop N, Zhang Z, Marchase RB et al. Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Am J Physiol Heart Circ Physiol 2007;292:H2227-H2236.
55. Fulop N, Marchase RB, Chatham JC. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res 2007;73:288-297.
56. Haider H, Ashraf M. Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 2008;45:554-566.
57. Dorn GW, 2nd. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 2009;81: 465-473.